What are the anatomical differences between asthma and Chronic Obstructive Pulmonary Disease (COPD) and how can they be differentiated in an emergency setting?

Anatomical and Pathophysiological Differences Between Asthma and COPD

Key Anatomical and Pathological Distinctions

Asthma primarily involves eosinophilic inflammation of the airways with reversible airflow limitation, while COPD is characterized by neutrophilic inflammation with irreversible structural damage to small airways and alveoli (emphysema). 1, 2

Structural Pathology

Asthma:

• Predominantly affects larger central airways with eosinophilic inflammation 2
• Airways remain structurally intact with potential for complete reversibility 1
• No emphysematous destruction of alveolar walls 3
• Normal diffusing capacity (DLCO) is maintained 3
• Airway wall thickening from smooth muscle hypertrophy and basement membrane thickening, but no permanent parenchymal destruction 2

COPD:

• Predominantly affects small peripheral airways with neutrophilic inflammation 2
• Permanent structural damage with emphysematous destruction of alveolar walls 1
• Decreased diffusing capacity (DLCO) reflecting extent of emphysema 3
• Loss of elastic recoil and airway collapse during expiration 3
• Irreversible airflow limitation from fixed airway narrowing and parenchymal destruction 1

Inflammatory Profiles

The inflammatory mediators differ substantially between the two conditions:

• COPD involves elevated IL-1β, IL-6, tumor necrosis factor-α, and neutrophil-derived proteases with increased neutrophils, macrophages, and CD8+ T lymphocytes 2
• Asthma demonstrates eosinophilic inflammation in typical adult cases, though severe asthma can show neutrophilic or mixed patterns 4, 2

---

Emergency Differentiation: Practical Clinical Approach

In the emergency setting, assume COPD if the patient is >50 years old, a long-term smoker or ex-smoker with chronic breathlessness on minor exertion, and no clear history of asthma. 4

Immediate Clinical Assessment

History clues that distinguish the conditions:

• Asthma: Often begins in childhood or adolescence, associated with atopy and allergies, dry cough mainly at night, paroxysmal dyspnea with complete symptom-free intervals 5
• COPD: Onset typically after age 40 in smokers, progressive dyspnea on exertion that worsens over time, productive cough with sputum, no symptom-free periods 4, 5

Critical Oxygen Management Pitfall

A major emergency pitfall: patients with COPD are at high risk of CO2 retention with excessive oxygen therapy, while asthmatics are not. 4

• 47% of COPD exacerbations have PaCO2 >45 mmHg, and 20% have respiratory acidosis 4
• Target oxygen saturation of 88-92% for suspected COPD patients to avoid worsening hypercapnic respiratory failure 4
• Asthma patients can safely receive high-flow oxygen without risk of CO2 retention 4
• If a patient receives excessive oxygen and develops respiratory acidosis, step down to 28% Venturi mask or 1-2 L/min nasal cannula rather than discontinuing oxygen abruptly 4

Bedside Spirometry (if patient stable enough)

Bronchodilator reversibility testing provides definitive differentiation:

• Asthma: >12% AND >200 mL improvement in FEV1 after bronchodilator administration 1, 6
• COPD: Post-bronchodilator FEV1/FVC <0.70 with minimal reversibility (<12% or <200 mL improvement) 1, 6
• Perform spirometry unless patient is too breathless to cooperate 4

Physical Examination Findings

Flow-volume curve patterns differ when available:

• Asthma shows concave downslope of flow-volume curve even in stable patients 3
• Severe COPD demonstrates flow in the second half of the curve smaller than rest-breathing 3

The Overlap Syndrome Caveat

Approximately 20% of patients with obstructive airway disease have features of both conditions (asthma-COPD overlap), which complicates emergency diagnosis. 4, 2

• These patients show both significant bronchodilator reversibility (≥12% and ≥200 mL) AND persistent baseline airflow limitation (FEV1/FVC <0.70) 1
• They have the highest mortality risk (HR 1.45) compared to COPD alone (HR 1.28) or asthma alone 4, 2
• In the emergency setting, treat with both ICS and bronchodilators if overlap is suspected 1

Other High-Risk Conditions for Hypercapnic Failure

Beyond COPD, assume risk of CO2 retention with oxygen therapy in:

• Patients already on long-term oxygen therapy 4
• Severe kyphoscoliosis or ankylosing spondylitis 4
• Morbid obesity (BMI >40 kg/m²) 4
• Neuromuscular disorders with wheelchair use 4
• Patients on home mechanical ventilation 4

Emergency Treatment Algorithm

For suspected COPD:

• Target SpO2 88-92% with controlled oxygen (28% Venturi mask or 1-2 L/min nasal cannula) 4
• Start with bronchodilators (LAMA or LABA) 1
• Add systemic corticosteroids only if eosinophilia or overlap features present 1

For suspected asthma:

• High-flow oxygen is safe; target SpO2 94-98% 4
• Aggressive bronchodilators (SABA) and systemic corticosteroids immediately 1
• ICS should be part of ongoing controller therapy 1